for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Emergent Biosolutions Signs Agreement To Be U.S. Manufacturing Partner For J&J's Lead Vaccine Candidate For COVID-19

April 23 (Reuters) - Emergent Biosolutions Inc:

* EMERGENT BIOSOLUTIONS SIGNS AGREEMENT TO BE U.S. MANUFACTURING PARTNER FOR JOHNSON & JOHNSON’S LEAD VACCINE CANDIDATE FOR COVID-19

* AGREEMENT VALUED AT APPROXIMATELY $135 MILLION

* EMERGENT BIOSOLUTIONS - UNDER AGREEMENT, WILL PROVIDE DRUG SUBSTANCE MANUFACTURING SERVICES WITH ITS MOLECULE-TO-MARKET CDMO OFFERING Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up